A092040 logo

Amicogen, Inc. Stock Price

KOSDAQ:A092040 Community·₩167.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A092040 Share Price Performance

₩3,060.00
-1705.00 (-35.78%)
₩3,060.00
-1705.00 (-35.78%)
Price ₩3,060.00

A092040 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Slightly overvalued with imperfect balance sheet.

1 Risk
0 Rewards

Amicogen, Inc. Key Details

₩117.7b

Revenue

₩87.7b

Cost of Revenue

₩30.1b

Gross Profit

₩79.7b

Other Expenses

-₩49.6b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-898.08
25.54%
-42.16%
95.3%
View Full Analysis

About A092040

Founded
2000
Employees
236
CEO
Piao Zhe
WebsiteView website
www.amicogen.com

Amicogen, Inc. operates as an industrial biotechnology company in South Korea and internationally. The company develops, produces, and sells of enzymes and new materials; and produces food-related additives and health functional food. It manufactures and sells of biopharmaceutical materials and resins for purifying pharmaceutical proteins and health and beauty products. In addition, the company offers oral incurable and rare disease treatments, as well as manufactures and sells of pharmaceutical raw materials, animal drugs, human drugs, etc. The company was incorporated in 2000 and is headquartered in Jinju-Si, South Korea.

Recent A092040 News & Updates

The Market Doesn't Like What It Sees From Amicogen, Inc.'s (KOSDAQ:092040) Revenues Yet

Sep 08
The Market Doesn't Like What It Sees From Amicogen, Inc.'s (KOSDAQ:092040) Revenues Yet

Recent updates

No updates